Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

Coronary artery disease is a widespread and serious condition, affecting 1 in 20 adults age 20 and older. But manypeople ...

Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment ...

Background: Middle-aged and older endurance athletes have increased prevalence of coronary artery disease (CAD) on coronary CT angiography (CCTA) compared to healthy controls, despite similarly low ...

Men begin developing coronary heart disease - which can lead to heart attacks - years earlier than women, with differences ...

Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.

Robocath announced today that it launched a first-in-human clinical study evaluating its new robotic system in coronary artery disease.

Researchers have created a new noninvasive technique for performing a type of artery bypass that may change the future of some coronary surgeries.

Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart ...

Historical data indicate that men develop coronary heart disease (CHD) 10 years before women. A study in the Journal of the ...

Valentine’s Day is coming up, and February is officially American Heart Month. Once again, Compass Peak Imaging in Glenwood ...

When we think about fat, we most often think about white fat cells, which store excess calories like so many batteries, ...